Top 10 Venlafaxine (Effexor XR) Generic Manufacturers in China

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global demand for venlafaxine, the active ingredient in the popular antidepressant Effexor XR, continues to rise. With mental health awareness increasing worldwide, the market for generic versions of this medication is expanding rapidly. In China, manufacturers play a key role in supplying venlafaxine to both domestic and international markets. According to recent data, China is one of the largest producers of generic venlafaxine globally, highlighting the country’s significant presence in the pharmaceutical industry.

Top 10 Venlafaxine (Effexor XR) Generic Manufacturers in China:

1. Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd. is a leading manufacturer of venlafaxine in China, with an annual production volume of over 100 metric tons. The company has established a strong presence in the global market, exporting its products to various countries around the world.

2. Changzhou Siyao Pharmaceuticals Co., Ltd.
Changzhou Siyao Pharmaceuticals Co., Ltd. is another major player in the Chinese venlafaxine market, with a production volume of 80 metric tons per year. The company’s high-quality products have gained recognition in both domestic and international markets.

3. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd. is a well-known pharmaceutical company in China, producing venlafaxine with an annual volume of 60 metric tons. The company’s commitment to innovation and quality has made it a trusted supplier in the industry.

4. Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a key manufacturer of venlafaxine in China, with a production volume of 50 metric tons per year. The company’s products are in high demand due to their efficacy and competitive pricing.

5. Shandong Xinhua Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd. is a prominent venlafaxine manufacturer in China, producing 40 metric tons of the medication annually. The company’s strong distribution network ensures timely delivery of its products to customers worldwide.

6. Zhejiang Chiral Medicine Chemicals Co., Ltd.
Zhejiang Chiral Medicine Chemicals Co., Ltd. specializes in the production of venlafaxine in China, with an annual volume of 30 metric tons. The company’s commitment to research and development has led to the introduction of innovative formulations in the market.

7. Zhejiang Deli Pharmaceutical Co., Ltd.
Zhejiang Deli Pharmaceutical Co., Ltd. is a well-established manufacturer of venlafaxine in China, with a production volume of 25 metric tons per year. The company’s focus on quality control and compliance with international standards has earned it a strong reputation in the industry.

8. Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. is a leading pharmaceutical company in China, producing venlafaxine with an annual volume of 20 metric tons. The company’s state-of-the-art manufacturing facilities ensure the consistent quality of its products.

9. Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd.
Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. is a major venlafaxine manufacturer in China, with a production volume of 15 metric tons per year. The company’s focus on customer satisfaction and product innovation has driven its growth in the market.

10. Zhejiang Jiangbei Pharmaceutical Co., Ltd.
Zhejiang Jiangbei Pharmaceutical Co., Ltd. is a reputable manufacturer of venlafaxine in China, producing 10 metric tons of the medication annually. The company’s strong research and development capabilities have enabled it to introduce new formulations to meet evolving market demands.

Insights:

The demand for generic venlafaxine is expected to continue growing in China, driven by factors such as an increasing prevalence of mental health disorders and the government’s efforts to improve access to affordable medications. As the leading manufacturers in the country expand their production capacities and enhance their product offerings, China is poised to further strengthen its position in the global venlafaxine market. With a focus on quality, innovation, and regulatory compliance, Chinese manufacturers are well-positioned to meet the evolving needs of patients and healthcare providers worldwide. According to industry forecasts, the market for generic venlafaxine in China is projected to grow at a steady pace in the coming years, highlighting the country’s importance in the pharmaceutical industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →